Botanix Pharmaceuticals Limited

Informe acción ASX:BOT

Capitalización de mercado: AU$645.2m

Botanix Pharmaceuticals Dirección

Dirección controles de criterios 1/4

El CEO de Botanix Pharmaceuticals es Howie McKibbon , nombrado en Aug 2023, tiene una permanencia de 1.25 años. compensación anual total es A$3.92M, compuesta por 15.3% salario y 84.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.22% de las acciones de la empresa, por valor de A$1.42M. La antigüedad media del equipo directivo y de la junta directiva es de 1 años y 5.3 años, respectivamente.

Información clave

Howie McKibbon

Chief Executive Officer (CEO)

AU$3.9m

Compensación total

Porcentaje del salario del CEO15.3%
Permanencia del CEO1.3yrs
Participación del CEO0.2%
Permanencia media de la direcciónless than a year
Promedio de permanencia en la Junta Directiva5.3yrs

Actualizaciones recientes de la dirección

Recent updates

Will Botanix Pharmaceuticals (ASX:BOT) Spend Its Cash Wisely?

Mar 21
Will Botanix Pharmaceuticals (ASX:BOT) Spend Its Cash Wisely?

Here's Why We're Watching Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

Sep 06
Here's Why We're Watching Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

Botanix Pharmaceuticals (ASX:BOT) Will Have To Spend Its Cash Wisely

Jan 03
Botanix Pharmaceuticals (ASX:BOT) Will Have To Spend Its Cash Wisely

Can Botanix Pharmaceuticals (ASX:BOT) Afford To Invest In Growth?

Sep 05
Can Botanix Pharmaceuticals (ASX:BOT) Afford To Invest In Growth?

Here's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

May 10
Here's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

We're Not Very Worried About Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate

Jan 12
We're Not Very Worried About Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate

We Think Botanix Pharmaceuticals (ASX:BOT) Can Afford To Drive Business Growth

Jul 01
We Think Botanix Pharmaceuticals (ASX:BOT) Can Afford To Drive Business Growth

We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

Mar 18
We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

The Botanix Pharmaceuticals (ASX:BOT) Share Price Has Gained 81% And Shareholders Are Hoping For More

Jan 24
The Botanix Pharmaceuticals (ASX:BOT) Share Price Has Gained 81% And Shareholders Are Hoping For More

We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

Nov 30
We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Howie McKibbon en comparación con los beneficios de Botanix Pharmaceuticals?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024AU$4mAU$602k

-AU$14m

Mar 31 2024n/an/a

-AU$12m

Dec 31 2023n/an/a

-AU$10m

Sep 30 2023n/an/a

-AU$10m

Jun 30 2023AU$1mAU$542k

-AU$9m

Mar 31 2023n/an/a

-AU$10m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$12m

Jun 30 2022AU$585kAU$126k

-AU$13m

Compensación vs. Mercado: La compensación total de Howie($USD2.54M) está por encima de la media de empresas de tamaño similar en el mercado Australian ($USD927.07K).

Compensación vs. Ingresos: La compensación de Howie ha aumentado mientras la empresa no es rentable.


CEO

Howie McKibbon

1.3yrs

Permanencia

AU$3,923,813

Compensación

Dr. Howie McKibbon serves as Chief Executive Officer since August 24, 2023 and was its Chief Operating Officer since October 2022 until August 24, 2023. He served as Chief Commercial Officer at Botanix Pha...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Vincent Ippolito
MD & Executive Chairman5.3yrsAU$612.70k0.59%
A$ 3.8m
Howie McKibbon
Chief Executive Officer1.3yrsAU$3.92m0.22%
A$ 1.4m
Graeme Morissey
Chief Financial Officerless than a yearAU$186.22ksin datos
Matthew Callahan
Executive Director4.8yrsAU$357.12k4.1%
A$ 26.5m
Jack Hoblitzell
Senior Vice President of Pharmaceutical Development3.8yrssin datossin datos
Patricia Walker
Chief Medical Adviser2.8yrssin datossin datos
Boris Meyerson
Chief Business Officerless than a yearsin datossin datos
David Morgan
Head of Corporate Affairsless than a yearsin datossin datos
Kevin Wojciechowski
Head of HCP Marketing & Sales Trainingless than a yearsin datossin datos
Susan Park
Company Secretary1.6yrssin datossin datos
Darin Van Arsdale
Director of Sales Operationsless than a yearsin datossin datos

1.0yrs

Permanencia media

58yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de BOT no se considera experimentado ( 1 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Vincent Ippolito
MD & Executive Chairman5.3yrsAU$612.70k0.59%
A$ 3.8m
Matthew Callahan
Executive Director4.8yrsAU$357.12k4.1%
A$ 26.5m
Stewart Washer
Independent Non-Executive Director5.8yrsAU$61.57k0.12%
A$ 770.4k
Henry Bosch
Non Executive Director8.3yrsAU$227.16k1.04%
A$ 6.7m
Daniel Sharp
Non-Executive Director2.7yrsAU$88.49k0.12%
A$ 756.6k

5.3yrs

Permanencia media

54yo

Promedio de edad

Junta con experiencia: La junta directiva de BOT se considera experimentada (5.3 años de antigüedad promedio).